The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company has C$16.63 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | C$17.18 B | 18.36% |
2023-12-31 | C$14.51 B | 14.96% |
2022-12-31 | C$12.62 B | 23.27% |
2021-12-31 | C$10.24 B | -24.55% |
2020-12-31 | C$13.57 B | 16.65% |
2019-12-31 | C$11.63 B | -70.84% |
2018-12-31 | C$39.91 B | -23.82% |
2017-12-31 | C$52.39 B | 2.38% |
2016-12-31 | C$51.18 B | 17.57% |
2015-12-31 | C$43.53 B | 38.8% |
2014-12-31 | C$31.36 B | 51.86% |
2013-12-31 | C$20.65 B | -13.68% |
2012-12-31 | C$23.92 B | 13.96% |
2011-12-31 | C$20.99 B | 20.56% |
2010-12-31 | C$17.41 B | 23.13% |
2009-12-31 | C$14.14 B | 21.78% |
2008-12-31 | C$11.61 B | 62.81% |
2007-12-31 | C$7.13 B | -2.39% |
2006-12-31 | C$7.30 B | 19.45% |
2005-12-31 | C$6.11 B | -12.3% |
2004-12-31 | C$6.97 B | 4.97% |
2003-12-31 | C$6.64 B | -9.78% |
2002-12-31 | C$7.36 B | 73.69% |
2001-12-31 | C$4.24 B | 39.58% |
2000-12-31 | C$3.03 B | 58.04% |
1999-12-31 | C$1.92 B | 521.81% |
1998-12-31 | C$0.30 B | -9.49% |
1997-12-31 | C$0.34 B | 47.32% |
1996-12-31 | C$0.23 B |